ホーム > 市場調査レポート > 医薬品

パイプライン分析

市場調査レポート

商品コード

1786799

NAMPT阻害剤市場：市場規模、シェア、動向、産業分析（分子タイプ別、フェーズ別、投与経路別、用途別、地域別）と将来予測（2025年～2034年）

NAMPT Inhibitors Market Size, Share, Trends, & Industry Analysis Report By Type of Molecule (Small Molecules and Biologics), By Phase, By Route of Administration, By Application, and By Region - Market Forecast, 2025-2034

出版日: 2025年07月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 635,502円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 785,032円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 934,562円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.53円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、NAMPT阻害剤の市場規模は2034年までに55億2,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

NAMPT阻害剤市場は、製薬会社が細胞のエネルギー代謝を標的とした新しい治療法の開発に注力していることから成長しています。NAMPTはニコチンアミドアデニンジヌクレオチド（NAD+）生合成経路の重要な酵素であり、がん細胞の成長と生存を支えています。この酵素を阻害すると、腫瘍細胞へのエネルギー供給が制限され、治療に対してより脆弱になります。

現在進行中の臨床調査と前臨床試験の進歩が、がん領域のパイプラインにおけるNAMPT阻害剤の採用を後押ししています。これらの阻害剤は、治療効果を改善するために単独療法と併用療法の両方が検討されています。バイオテクノロジー企業や製薬企業の関心が高まっていることに加え、標的がん治療薬に対する規制当局のサポート体制が整っていることが、市場の成長を加速させています。

NAMPT阻害剤市場レポートハイライト

分子タイプ別では、低分子化合物が良好な薬物動態を示し、製剤化が容易であり、がん治療薬の市場開拓において確立された役割を果たすことから、2024年の市場シェアは低分子化合物が優位を占めました。

フェーズ別では、前臨床部門が2024年の市場を独占しました。これは、ほとんどのNAMPT阻害薬プログラムが初期段階にあるためであり、候補化合物はin vitroおよびin vivoで広範な試験が実施され、有効性、毒性、薬力学的特性が評価されます。

投与経路別では、制御されたドラッグデリバリー、安定したバイオアベイラビリティ、迅速な全身曝露が可能な静脈内投与が2024年の市場を独占しました。

用途別では、白血病やリンパ腫などの血液がんの治療における役割の拡大や、この領域での臨床研究活動の活発化に支えられ、血液内科領域が2034年までに最も高い成長率を示すと予測されています。

2024年のNAMPT阻害剤の世界市場では、がん研究および初期段階の創薬への多額の投資により、北米が大半のシェアを占めています。

アジア太平洋は最も急速に成長している市場であり、この地域のバイオテクノロジー状況の拡大と国際共同研究への関与の拡大がその要因となっています。

世界の主要市場企業には、AbbVie Inc.、Angelini Pharma S.p.A.、Antengene Therapeutics Limited、Aqualung Therapeutics Corporation、AstraZeneca plc、Bayer AG、Boehringer Ingelheim GmbH、Calico LLC、FORMA Therapeutics, Inc.、Genentech, Inc.、GlaxoSmithKline plc（GSK plc）、Johnson &Johnson Services, Inc.、Karyopharm Therapeutics Inc.、Merck &Co.

主な調査結果
イントロダクション
- NAMPT阻害剤市場分析：地域別、2020年～2034年
北米
- 北米：分子タイプ別、2020年～2034年
- 北米：フェーズ別、2020年～2034年
- 北米：投与経路別、2020年～2034年
- 北米：用途別、2020年～2034年
- 米国
- カナダ
欧州
- 欧州：分子タイプ別、2020年～2034年
- 欧州：段階別、2020年～2034年
- 欧州：投与経路別、2020年～2034年
- 欧州：用途別、2020年～2034年
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
- その他欧州
アジア太平洋
- アジア太平洋：分子タイプ別、2020年～2034年
- アジア太平洋：フェーズ別、2020年～2034年
- アジア太平洋：投与経路別、2020年～2034年
- アジア太平洋：用途別、2020年～2034年
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋
中東・アフリカ
- 中東・アフリカ：分子タイプ別、2020年～2034年
- 中東・アフリカ：フェーズ別、2020年～2034年
- 中東・アフリカ：投与経路別、2020年～2034年
- 中東・アフリカ：用途別、2020年～2034年
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東・アフリカ
ラテンアメリカ
- ラテンアメリカ：分子タイプ別、2020-2034年
- ラテンアメリカ：フェーズ別、2020年～2034年
- ラテンアメリカ：投与経路別、2020年～2034年
- ラテンアメリカ：用途別、2020年～2034年
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ

第10章競合情勢

拡大と買収の分析
- 拡大
- 買収
提携/協業/合意/公開

第11章企業プロファイル

AbbVie Inc.
Angelini Pharma S.p.A.
Antengene Therapeutics Limited
Aqualung Therapeutics Corporation
AstraZeneca plc
Bayer AG
Boehringer Ingelheim GmbH
Calico LLC
FORMA Therapeutics, Inc.
Genentech, Inc.
GlaxoSmithKline plc（GSK plc）
Johnson & Johnson Services, Inc.

図表

List of Tables:

Table 1 Global NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 2 Global NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 3 Global NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 4 Global NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 5 North America: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 6 North America: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 7 North America: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 8 North America: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 9 U.S.: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 10 U.S.: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 11 U.S.: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 12 U.S.: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 13 Canada: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 14 Canada: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 15 Canada: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 16 Canada: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 17 Europe: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 18 Europe: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 19 Europe: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 20 Europe: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 21 UK: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 22 UK: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 23 UK: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 24 UK: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 25 France: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 26 France: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 27 France: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 28 France: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 29 Germany: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 30 Germany: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 31 Germany: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 32 Germany: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 33 Italy: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 34 Italy: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 35 Italy: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 36 Italy: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 37 Spain: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 38 Spain: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 39 Spain: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 40 Spain: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 41 Netherlands: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 42 Netherlands: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 43 Netherlands: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 44 Netherlands: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 45 Russia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 46 Russia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 47 Russia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 48 Russia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 49 Rest of Europe: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 50 Rest of Europe: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 51 Rest of Europe: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 52 Rest of Europe: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 53 Asia Pacific: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 54 Asia Pacific: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 55 Asia Pacific: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 56 Asia Pacific: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 57 China: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 58 China: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 59 China: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 60 China: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 61 India: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 62 India: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 63 India: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 64 India: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 65 Malaysia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 66 Malaysia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 67 Malaysia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 68 Malaysia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 69 Japan: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 70 Japan: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 71 Japan: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 72 Japan: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 73 Indonesia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 74 Indonesia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 75 Indonesia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 76 Indonesia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 77 South Korea: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 78 South Korea: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 79 South Korea: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 80 South Korea: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 81 Australia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 82 Australia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 83 Australia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 84 Australia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 85 Rest of Asia Pacific: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 86 Rest of Asia Pacific: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 87 Rest of Asia Pacific: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 88 Rest of Asia Pacific: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 89 Middle East & Africa: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 90 Middle East & Africa: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 91 Middle East & Africa: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 92 Middle East & Africa: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 93 Saudi Arabia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 94 Saudi Arabia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 95 Saudi Arabia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 96 Saudi Arabia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 97 UAE: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 98 UAE: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 99 UAE: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 100 UAE: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 101 Israel: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 102 Israel: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 103 Israel: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 104 Israel: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 105 South Africa: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 106 South Africa: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 107 South Africa: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 108 South Africa: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 109 Rest of Middle East & Africa: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 110 Rest of Middle East & Africa: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 111 Rest of Middle East & Africa: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 112 Rest of Middle East & Africa: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 113 Latin America: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 114 Latin America: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 115 Latin America: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 116 Latin America: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 117 Mexico: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 118 Mexico: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 119 Mexico: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 120 Mexico: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 121 Brazil: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 122 Brazil: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 123 Brazil: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 124 Brazil: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 125 Argentina: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 126 Argentina: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 127 Argentina: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 128 Argentina: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
Table 129 Rest of Latin America: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
Table 130 Rest of Latin America: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
Table 131 Rest of Latin America: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
Table 132 Rest of Latin America: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global NAMPT Inhibitors Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Type of Molecule
Figure 7. Global NAMPT Inhibitors Market, by Type of Molecule, 2024 & 2034 (USD Billion)
Figure 8. Market by Phase
Figure 9. Global NAMPT Inhibitors Market, by Phase, 2024 & 2034 (USD Billion)
Figure 10. Market by Route of Administration
Figure 11. Global NAMPT Inhibitors Market, by Route of Administration, 2024 & 2034 (USD Billion)
Figure 12. Market by Application
Figure 13. Global NAMPT Inhibitors Market, by Application, 2024 & 2034 (USD Billion)

Product Code: PM6100

The NAMPT inhibitors market size is expected to reach USD 5.52 Billion by 2034, according to a new study by Polaris Market Research. The report "NAMPT Inhibitors Market Size, Share, Trends, & Industry Analysis Report By Type of Molecule (Small Molecules and Biologics), By Phase, By Route of Administration, By Application, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The NAMPT inhibitors market is growing as pharmaceutical companies focus on developing new therapies targeting cellular energy metabolism. NAMPT is a key enzyme in the Nicotinamide Adenine Dinucleotide (NAD+) biosynthesis pathway, which supports cancer cell growth and survival. Inhibiting this enzyme helps limit energy supply to tumor cells, making them more vulnerable to treatment.

Ongoing clinical research and preclinical advancements are driving the adoption of NAMPT inhibitors across oncology pipelines. These inhibitors are explored as both standalone and combination therapies to improve treatment response. The growing interest from biotech and pharmaceutical firms, along with supportive regulatory pathways for targeted oncology drugs, is accelerating the market growth.

NAMPT Inhibitors Market Report Highlights

Based on type of molecule, the small molecules segment dominated the market share in 2024, due to its favorable pharmacokinetics, ease of formulation, and established role in oncology drug development.

In terms of phase, the preclinical segment dominated the market in 2024. This is owing to the early stage of most NAMPT inhibitor programs, as candidates undergo extensive in vitro and in vivo testing to evaluate efficacy, toxicity, and pharmacodynamic properties.

In terms of route of administration, the intravenous (IV) administration segment dominated the market in 2024, attributed to its ability to ensure controlled drug delivery, consistent bioavailability, and rapid systemic exposure.

Based on application, the hematology segment is projected to grow at the highest rate by 2034, driven by its expanding role in the treatment of blood cancers such as leukemia and lymphoma, supported by growing clinical research activity in this area.

North America accounted for the majority share in the global NAMPT inhibitors market in 2024, due to substantial investments in oncology research and early-phase drug discovery.

Asia Pacific is the fastest growing market, driven by the expanding regional biotech landscape and greater involvement in international research collaborations.

A few global key market players include AbbVie Inc., Angelini Pharma S.p.A., Antengene Therapeutics Limited, Aqualung Therapeutics Corporation, AstraZeneca plc, Bayer AG, Boehringer Ingelheim GmbH, Calico LLC, FORMA Therapeutics, Inc., Genentech, Inc., GlaxoSmithKline plc (GSK plc), Johnson & Johnson Services, Inc., Karyopharm Therapeutics Inc., Merck & Co., Inc., and Novartis AG.

Polaris Market Research has segmented the market report on the basis of type of molecule, phase, route of administration, application, and region:

By Type of Molecule Outlook (Revenue, USD Billion, 2020-2034)

Small Molecules

Biologics

By Phase Outlook (Revenue, USD Billion, 2020-2034)

Phase I

Phase II

Phase I/II

Preclinical

By Route of Administration Outlook (Revenue, USD Billion, 2020-2034)

Oral

Intravenous

By Application Outlook (Revenue, USD Billion, 2020-2034)

Oncology

Hematology

Inflammatory and Metabolic Diseases

Neurology

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global NAMPT Inhibitors Market Insights

4.1. NAMPT Inhibitors Market - Market Snapshot
4.2. NAMPT Inhibitors Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Supportive Regulatory and Funding Environment
  - 4.2.1.2. Increasing Global Cancer Burden
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Toxicity and Safety Concerns
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. NAMPT Inhibitors Market Trends
4.6. Value Chain Analysis

5. Global NAMPT Inhibitors Market, by Type of Molecule

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
5.3. Small Molecules
- 5.3.1. Global NAMPT Inhibitors Market, by Small Molecules, by Region, 2020-2034 (USD Billion)
5.4. Biologics
- 5.4.1. Global NAMPT Inhibitors Market, by Biologics, by Region, 2020-2034 (USD Billion)

6. Global NAMPT Inhibitors Market, by Phase

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
6.3. Phase I
- 6.3.1. Global NAMPT Inhibitors Market, by Phase I, by Region, 2020-2034 (USD Billion)
6.4. Phase II
- 6.4.1. Global NAMPT Inhibitors Market, by Phase II, by Region, 2020-2034 (USD Billion)
6.5. Phase I/II
- 6.5.1. Global NAMPT Inhibitors Market, by Phase I/II, by Region, 2020-2034 (USD Billion)
6.6. Preclinical
- 6.6.1. Global NAMPT Inhibitors Market, by Preclinical, by Region, 2020-2034 (USD Billion)

7. Global NAMPT Inhibitors Market, by Route of Administration

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
7.3. Oral
- 7.3.1. Global NAMPT Inhibitors Market, by Oral, by Region, 2020-2034 (USD Billion)
7.4. Intravenous
- 7.4.1. Global NAMPT Inhibitors Market, by Intravenous, by Region, 2020-2034 (USD Billion)

8. Global NAMPT Inhibitors Market, by Application

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
8.3. Oncology
- 8.3.1. Global NAMPT Inhibitors Market, by Oncology, by Region, 2020-2034 (USD Billion)
8.4. Hematology
- 8.4.1. Global NAMPT Inhibitors Market, by Hematology, by Region, 2020-2034 (USD Billion)
8.5. Inflammatory and Metabolic Diseases
- 8.5.1. Global NAMPT Inhibitors Market, by Inflammatory and Metabolic Diseases, by Region, 2020-2034 (USD Billion)
8.6. Neurology
- 8.6.1. Global NAMPT Inhibitors Market, by Neurology, by Region, 2020-2034 (USD Billion)
8.7. Others
- 8.7.1. NAMPT Inhibitors Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global NAMPT Inhibitors Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. NAMPT Inhibitors Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. NAMPT Inhibitors Market - North America
- 9.3.1. North America: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
- 9.3.2. North America: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
- 9.3.3. North America: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.3.4. North America: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.3.5. NAMPT Inhibitors Market - U.S.
  - 9.3.5.1. U.S.: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.3.5.2. U.S.: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.3.5.3. U.S.: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.3.5.4. U.S.: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.3.6. NAMPT Inhibitors Market - Canada
  - 9.3.6.1. Canada: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
9.4. NAMPT Inhibitors Market - Europe
- 9.4.1. Europe: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
- 9.4.2. Europe: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
- 9.4.3. Europe: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.4. Europe: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.4.5. NAMPT Inhibitors Market - UK
  - 9.4.5.1. UK: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.4.6. NAMPT Inhibitors Market - France
  - 9.4.6.1. France: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.4.6.2. France: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.6.3. France: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.6.4. France: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.4.7. NAMPT Inhibitors Market - Germany
  - 9.4.7.1. Germany: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.7.3. Germany: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.4.8. NAMPT Inhibitors Market - Italy
  - 9.4.8.1. Italy: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.4.9. NAMPT Inhibitors Market - Spain
  - 9.4.9.1. Spain: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.4.10. NAMPT Inhibitors Market - Netherlands
  - 9.4.10.1. Netherlands: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.4.11. NAMPT Inhibitors Market - Russia
  - 9.4.11.1. Russia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.4.12. NAMPT Inhibitors Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
9.5. NAMPT Inhibitors Market - Asia Pacific
- 9.5.1. Asia Pacific: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.5.5. NAMPT Inhibitors Market - China
  - 9.5.5.1. China: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.5.5.2. China: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.5.3. China: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.5.4. China: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.5.6. NAMPT Inhibitors Market - India
  - 9.5.6.1. India: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.5.6.2. India: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.6.3. India: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.6.4. India: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.5.7. NAMPT Inhibitors Market - Malaysia
  - 9.5.7.1. Malaysia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.5.8. NAMPT Inhibitors Market - Japan
  - 9.5.8.1. Japan: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.5.9. NAMPT Inhibitors Market - Indonesia
  - 9.5.9.1. Indonesia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.5.10. NAMPT Inhibitors Market - South Korea
  - 9.5.10.1. South Korea: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.5.11. NAMPT Inhibitors Market - Australia
  - 9.5.11.1. Australia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.5.12. NAMPT Inhibitors Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
9.6. NAMPT Inhibitors Market - Middle East & Africa
- 9.6.1. Middle East & Africa: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.6.5. NAMPT Inhibitors Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.6.6. NAMPT Inhibitors Market - UAE
  - 9.6.6.1. UAE: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.6.7. NAMPT Inhibitors Market - Israel
  - 9.6.7.1. Israel: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.6.8. NAMPT Inhibitors Market - South Africa
  - 9.6.8.1. South Africa: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.6.9. NAMPT Inhibitors Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
9.7. NAMPT Inhibitors Market - Latin America
- 9.7.1. Latin America: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
- 9.7.2. Latin America: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
- 9.7.3. Latin America: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.7.4. Latin America: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.7.5. NAMPT Inhibitors Market - Mexico
  - 9.7.5.1. Mexico: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.7.6. NAMPT Inhibitors Market - Brazil
  - 9.7.6.1. Brazil: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.7.7. NAMPT Inhibitors Market - Argentina
  - 9.7.7.1. Argentina: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
- 9.7.8. NAMPT Inhibitors Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. AbbVie Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Angelini Pharma S.p.A.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Antengene Therapeutics Limited
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Aqualung Therapeutics Corporation
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. AstraZeneca plc
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Bayer AG
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Boehringer Ingelheim GmbH
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Calico LLC
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. FORMA Therapeutics, Inc.
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Genentech, Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. GlaxoSmithKline plc (GSK plc)
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Johnson & Johnson Services, Inc.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development

ライセンス / 価格

PDF (Single User License)

USD 4,250 635,502円

その他のライセンス / 価格

PDF (Multi User License)

USD 5,250 785,032円

PDF (Enterprise License)

USD 6,250 934,562円

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.53円

お電話でのお問い合わせ

044-952-0102

( 土日・祝日を除く )

最近チェックしたレポート

オルタナティブ金融市場：タイプ別、エンドユーザー別-2025-2030年の世界予測

サンプル依頼リスト

小口径弾薬市場：世界の産業規模・シェア・動向・機会・予測 (サイズ別、用途別、地域別)、競合情勢 (2019～2029年)

サンプル依頼リスト

当社から購入するメリット

調査会社200社超のレポート比較
充実したサポート体制
日本円での後払い
無料AI翻訳ツールの提供

よくあるご質問

NAMPT阻害剤市場：市場規模、シェア、動向、産業分析（分子タイプ別、フェーズ別、投与経路別、用途別、地域別）と将来予測（2025年～2034年）